A controlled experiment in mice found that administering olive oil before a glucose challenge produced a smaller early rise in blood sugar compared with two other conditions. The investigators gave olive oil 15 minutes before an oral glucose tolerance–style load; another group received water beforehand, and a third group received olive oil after the glucose load. The mice that received oil before the glucose showed both a blunted early glucose excursion and delayed gastric emptying. The authors extended these observations to murine models of type 2 diabetes and severe insulin deficiency and reported similar short-term effects in those models.
The source did not provide human-level dosing equivalencies for the murine regimen, and it reported the animal preload dose as 5 mL per kilogram of body weight. The study protocol, sample sizes, randomization procedures and other detailed methods were not described in the article beyond the preload timings and comparative groups.
Data indicated that the olive oil preload provoked earlier and larger increases in gut peptides — including GLP-1, GIP, and glucagon — within 15–30 minutes after the preload. The study team observed that these hormonal surges coincided with signals that slow stomach emptying, a mechanism that delays the arrival of glucose to the small intestine. Investigators reported that this coordinated hormone–nerve response reduced how quickly glucose appeared in the circulation after the oral load.
Experts interviewed in the article described the physiology in concrete terms. One nutrition specialist explained that fat in the small intestine stimulates incretin release, which then feeds back to slow gastric transit via hormonal pathways and vagal signaling. Another commentator noted that the blunted early glucose rise occurred without a substantial increase in insulin secretion in the mouse model, implying gastric emptying changes rather than enhanced insulin production as the primary mechanism.
The article noted prior human data consistent with the mechanism observed in mice. It cited a small randomized crossover study involving six men with type 2 diabetes in which consuming 30 mL of olive oil 30 minutes before a carbohydrate-rich meal slowed gastric emptying, delayed the rise in blood glucose, and increased GLP-1 secretion compared with water or consuming oil mixed into the meal. The source also referenced a small study where eating protein or fish before rice delayed gastric emptying and improved postprandial glycemia.
These human reports were small and acute. The source did not claim long-term benefits or show changes in glycemic control measures used in clinical practice, such as HbA1c, nor did it report outcomes related to weight, cardiovascular events, or medication needs. Those endpoints were explicitly identified as outside the scope of the presented studies.
The social media trend of taking concentrated olive oil shots — sometimes combined with lemon, black pepper, or turmeric — carries practical tolerability and safety concerns described by the experts. The article reported that concentrated oil taken rapidly can cause nausea, abdominal cramping, loose stools, or worsen reflux in susceptible individuals. One gastroenterologist warned that an oily or acidic bolus on an empty stomach may provoke gastrointestinal distress in people with sensitive digestive systems.
Combining olive oil with acidic ingredients raises dental concerns. The nutrition experts stated that frequent exposure to dietary acids, such as fresh lemon juice, contributes to dental erosion by softening enamel and promoting mineral loss. The article also highlighted the caloric density of olive oil: adding a daily shot could increase overall energy intake unless compensated elsewhere in the diet. The source reported there are currently no studies specifically assessing the safety profile of olive oil shots.
The authors and external experts emphasized key limitations. The primary dataset discussed in the article comes from mice; translation to humans is uncertain. The murine dose (5 mL/kg) may not reflect typical human dietary intake, and the controlled oral glucose challenge differs from real-world mixed meals. Slowing gastric emptying does not reduce total glucose absorption; it can shift the timing of peak glucose and may not improve long-term insulin sensitivity.
The article made clear that the studies do not address durable clinical outcomes — effects on HbA1c, weight trajectories, cardiovascular events, or changes in medication requirements were not reported. The source called for larger, well-controlled human trials to define optimal dosing, timing relative to meals, tolerability, and whether any short-term glycemic effects translate into meaningful long-term benefits. It also noted the absence of dedicated safety studies on daily olive oil shots, particularly when combined with acidic or spicy additives that may harm teeth or aggravate reflux.
These unanswered questions and the limits of animal-to-human inference were the final points raised in the source material. The piece stopped short of clinical recommendations and instead flagged the need for targeted human research before endorsing routine use of olive oil preloads for glycemic control.